Recommended neuroanatomical sampling practices for comprehensive brain evaluation in nonclinical safety studies. - Wikidata - awgldk - TriplyDB

Recommended neuroanatomical sampling practices for comprehensive brain evaluation in nonclinical safety studies.

Recommended neuroanatomical sampling practices for comprehensive brain evaluation in nonclinical safety studies.

http://www.wikidata.org/entity/Q37850209

about

Fundamentals of translational neuroscience in toxicologic pathology: optimizing the value of animal data for human risk assessment.Toxicologic Pathology Analysis for Translational Neuroscience: Improving Human Risk Assessment Using Optimized Animal Data.The use of time-lapse optical coherence tomography to image the effects of microapplied toxins on the retina.Subsite awareness in neuropathology evaluation of National Toxicology Program (NTP) studies: a review of select neuroanatomical structures with their functional significance in rodents Morphologic, stereologic, and morphometric evaluation of the nervous system in young cynomolgus monkeys (Macaca fascicularis) following maternal administration of tanezumab, a monoclonal antibody to nerve growth factor.Proliferative and nonproliferative lesions of the rat and mouse central and peripheral nervous systems.STP position paper: Recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies.Quantitative Assessment of MRI T2 Response to Kainic Acid Neurotoxicity in Rats in vivo.Neuroanatomy-based matrix-guided trimming protocol for the rat brain.

P2860

Q30869945-EA1B36DD-4DBB-4DD6-8CB1-C5534A62D48C Q31063026-D571F6DB-E39B-4A15-A239-812D31C9ACAF Q35981274-CCEDFF64-DD8D-470B-A0BB-B1B62F08D7A4 Q37662764-E2D59ACB-F5B1-468F-B0A5-7D0655DBB5A8 Q42467356-4B89588A-CE93-41E6-9ABB-70468B1A4FA3 Q46161445-6C3B258C-96BA-4C7A-A5E3-8189944A3BA4 Q48132372-F45E537A-0DCB-4696-B244-4D5B2064A754 Q48215314-909F0AEB-2C93-49BD-8921-834A6F0B92C6 Q48706580-1EE3D6AE-F400-4185-B8B3-6E1D918FCBCD

P2860

Recommended neuroanatomical sampling practices for comprehensive brain evaluation in nonclinical safety studies.

http://www.wikidata.org/entity/Q37850209

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recommended neuroanatomical sa ...... in nonclinical safety studies.

@en

Recommended neuroanatomical sa ...... in nonclinical safety studies.

@nl

type

label

Recommended neuroanatomical sa ...... in nonclinical safety studies.

@en

Recommended neuroanatomical sa ...... in nonclinical safety studies.

@nl

prefLabel

Recommended neuroanatomical sa ...... in nonclinical safety studies.

@en

Recommended neuroanatomical sa ...... in nonclinical safety studies.

@nl

P1433

Q37850209-03035E51-CAD6-4FF9-B6DF-B4E4B64853A2

P1476

Q37850209-5C29E8E3-D63F-485B-8A83-D22AFE04B403

P2093

Q37850209-AF857DB3-935B-4B20-94C9-C58B4C8C3A4B

Q37850209-D2D185D9-54C5-4518-BDDC-96D22E10B374

Q37850209-E6B3C821-08F4-408C-A261-C4F67ADC2326

P2860

Q37850209-033874C6-6B24-49F8-88C9-4ECFDF05BD81

Q37850209-03570B74-A7F1-4B4B-9854-F4C49BDC616F

Q37850209-0C8B505A-17DF-4934-93F9-96880465E21C

Q37850209-14070556-4F75-4217-BBD0-2875B1CFE5F6

Q37850209-1D5A2584-C49F-45B4-BEBC-D226F52458B8

Q37850209-2516E9F4-F3E0-4424-A806-3076FC027448

Q37850209-286F2756-C103-4DDA-AE1F-7D83E937203E

Q37850209-2AEE6BA7-441A-4E61-A5ED-7E33FBDD7C01

Q37850209-302B16E4-2CCB-4D05-8FBA-191920CA309F

Q37850209-4C3C399D-7EC4-4D36-AD0E-96A24065718C

P304

Q37850209-9482A612-9ED4-473E-A9C2-4B9485A7F133

P31

Q37850209-0FB1D975-F593-4F48-A1CB-9F7512428352

P356

Q37850209-E80D11BF-F687-41D6-A26C-E82763174B78

P407

Q37850209-DCE506FB-2233-491B-AA21-31A62523B6D9

P433

Q37850209-ABA83EEA-F479-411F-B5A9-A1F8702B648A

P478

Q37850209-550006E3-E99A-437A-A695-0F4E1E34775A

P577

Q37850209-EEBDBFE7-17AC-41E0-834A-023449D5EE32

P5875

Q37850209-1FE0B878-89F8-4C87-90AA-95C6695B9855

P698

Q37850209-632A14CA-D9CB-4BF7-924A-9C38B1FAEA43

P356

0192623310397557

P1433

Toxicologic Pathology

P1476

Recommended neuroanatomical sa ...... in nonclinical safety studies.

@en

P2093

Catherine Lowry-Franssen

http://www.w3.org/2001/XMLSchema#string

Robert C Switzer

http://www.w3.org/2001/XMLSchema#string

Stanley A Benkovic

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse.

d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity.

Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures

Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or d-amphetamine.

Application of silver degeneration stains for neurotoxicity testing.

P304

73-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0192623310397557

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50289400

http://www.w3.org/2001/XMLSchema#string

P698

21378207

http://www.w3.org/2001/XMLSchema#string